Same topic TROP2 · 2 people#CELLTHERAPY#TROP2#NSCLC#BREASTCANCER840 views29 likes10 reposts0 replies
AACR Annual Meeting 2026
April 17–22, 2026 · San Diego · 2418 items
TROP2
2 people · 2 posts
Heat trend for this story
Heat now 1·Peak in the comparable set 1 (Apr 22 06:00)·Change over 24h in the comparable set –·Participants now 1
Participants counted1
Heat over time
Other cases in this chapter
- T-DXd + pertuzumabPFS HR 0.56 (40.7 vs 26.9 mo)
- olaparib + T-DXdConfirmed PR 42.9%, mDOR 11.2 mo (n=28)
- risvutatugB7-H3 ADC, floor ORR ~47%
- zanidatamab 新辅助No-chemo pCR 30%, HER2 down 56%
- AVA6103 / pan-RAS ADCTricomplex pan-RAS as payload
Floor
x.com@ x.com@ Dr Sarah Sammons@drsarahsam TROPION-Breast02 brain mets analysis at #ESMO26 (Dent). 1L Dato-DXd vs chemo, mTNBC, n=61 with BMs:
Dr Riyaz Shah@DrRiyazShah Stephen V Liu, MD@StephenVLiu Dr. Antonio Calles 🫁🚭@Tony_Calles Dr. Egbert Smit cooling down expectations on ADCs in NSCLC.
Bio-Thera Solutions@bio_thera_sol